EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Securing the Pharma Supply Chain: Insights on Secondary Packaging from INTERPHEX 2026
What stood out to me at INTERPHEX was the stronger connection between manufacturing quality logistics and distribution Packaging is increasingly seen as part of the broader control strategy
Advisory Board
KNOWLEDGE BANK
-
Articles
The Architect of the Void: When 3D Printing Becomes the Body’s New Bone
In the quiet pressurised hum of a modern surgical suite a surgeon holds a highdefinition scan of a young patients femur On the screen a jagged dark shadow marks where an osteosarcoma has claimed its territory For decades the script for this moment has been written in cold hard steel
From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma
Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes
How Drug Patents Shape the Competitive Landscape in Pharma?
It can rightly be said that the business of pharmaceuticals is very sensitive and crucial since business is all about the manufacturing of change for the purpose of ridding the world of diseases
How Predictive Maintenance Reduces Downtime in Pharma Plants
The pharmaceutical industry is always under stress to enhance the reliability of the production adherence to the regulations and quality of the products without raising the prices and to maintain a continuous supply Machinery malfunctions are not merely a setback in this highstakes game they may compromise batch integrity postpone life and death treatments and put pressure on the market promises
Exploring the Benefits of Sustainable Clinical Trials
The landscape of clinical trials is evolving with a growing recognition that research endeavors should extend beyond scientific excellence to encompass broader societal environmental and economic considerations
How Mass Spectrometers Are Transforming the Study of Metabolomics
The mechanism of metabolomics can be described as a relatively young science which is rather popular in modern science and investigates metabolites which are the small molecules that take part in the metabolic processes inside the living organism This discipline therefore has great potential as a tool in proactively unraveling a diverse range of biological occurrences disease processes or even tre...
-
Techno Trends
Merck’s Calderasib Receives FDA Breakthrough Therapy Designation for Lung Cancer
Merck has secured a significant regulatory milestone for its investigational cancer therapy calderasib MK after the US Food and Drug Administration FDA granted the treatment Breakthrough Therapy designation
-
Projects
SCHOTT Pharma Invests $60M to Expand Glass Vial Production in Pennsylvania
SCHOTT Pharma has completed a major expansion of its manufacturing facility in Lebanon Pennsylvania with an investment exceeding USD million Supported largely by BARDA the project increases domestic production
-
Research Insights
Predicting unknown binding sites for transition-metal-based compounds in proteins
Transitionmetalbased compounds are promising therapeutic agents particularly in cancer treatment However predicting the binding sites of such compounds remains a major challenge In this work we investigate the applicabilit
-
whitepaper
Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch
Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities
TOP ARTICLES
-
1
From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma
Kavita Vengurlekar
Pharma companies can now see quality issues much earlier, thanks to digital systems. But faster visibility hasn’t always meant faster decisions. This article explains why the next step in qualit...
-
2
How Drug Patents Shape the Competitive Landscape in Pharma?
Kate Williamson
Drug patents are central in the pharmaceutical field because they offer marketing privileges over drugs, foster technological advancement, and control the market. They drive the research expenditure,...
-
3
How Predictive Maintenance Reduces Downtime in Pharma Plants
Kate Williamson
The reliability strategies within the pharmaceutical industry are changing with the predictive maintenance pharma practices. Through the application of pharmaceutical predictive analytics, IoT, and AI...
-
4
Exploring the Benefits of Sustainable Clinical Trials
Debi Jones
Sustainable clinical trials signify a transformative shift in research, integrating scientific rigor with environmental responsibility, resource efficiency, and community engagement. This paradigm enh...
-
5
How Mass Spectrometers Are Transforming the Study of Metabolomics
Kate Williamson
Mass spectrometry (MS) is being rapidly applied to metabolomics because both the sensitivity and accuracy of analysis of metabolites can easily be achieved using this technique. It refines knowledge o...
press releases Read more...
BioMed X Launches Innovation Circle at BIO International Convention 2026
BioMed X a buildtosolve innovation engine for pharma officially launched the BioMed X Innovation Circle during the BIO International Convention last week bringing together leaders from across the global
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
Novartis today announced that the European Commission EC has approved Itvisma onasemnogene abeparvovec for the treatment of children two years and older teens and adults living with q spinal muscular
Turkish Cargo has been Selected as the “Cargo Airline of the Year – Global” for the Second Consecutive Time
Turkish Airlines global air cargo brand Turkish Cargo was awarded Cargo Airline of the Year Global for the second consecutive time at the World Air Cargo Awards organized by Air Cargo Week
Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing
Lonza the worlds leading contract development and manufacturing organization CDMO today announced plans to enhance its druglinker center of excellence and expand payloadlinker manufacturing capacity at its Visp site
Events Read more...
07 - 09
Jul 2026The Pharma India Expo 2026
Bombay Exhibition Centre, Mumb...
07 - 09
Jul 2026Nanosciences and Nanotechnologies 2026
Thessaloniki, Greece
08 - 10
Jul 2026CPHI SEA 2026
QSNCC, Bangkok, Thailand
09 - 11
Jul 2026Pharma Pro&Pack Expo 2026
HITEX Exhibition Centre, Hyder...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
LATEST NEWS Read more...
Nona Biosciences and Lonza Collaborate on BBB-Crossing Technology for CNS Drug Development
Nona Biosciences has entered into a strategic collaboration with Lonza to develop singledomain antibodybased bloodbrain barrier BBBcrossing technology for the treatment of central nervous system CNS diseases
Vertex Secures US FDA Approval for Expanded Use of CASGEVY in Young Children
Vertex Pharmaceuticals has received approval from the US Food and Drug Administration FDA to expand the use of CASGEVY exagamglogene autotemcel for patients aged two years and older with sickle cell disease
Ipsen to acquire Kartos Therapeutics to strengthen late-stage haemato-oncology pipeline
Ipsen has entered into a definitive merger agreement to acquire Kartos Therapeutics adding the investigational MDM inhibitor navtemadlin to its latestage haematooncology pipeline
AstraZeneca and YMCA of the USA Partner to Expand Cancer Education and Support Services
AstraZeneca and YMCA of the USA YUSA have announced a fiveyear partnership aimed at improving cancer education increasing awareness of screening and early detection and expanding support programmes for cancer survivors
Merck Partners with Saturnus Bio to Develop Treatments for Rare Genetic Cardiomyopathies
Merck has entered into a strategic researchstage collaboration with Saturnus Bio a biotechnology company founded by Versant Ventures to build a portfolio of therapies for rare genetic cardiomyopathies
Quoin Receives FDA Conditional Approval for QYLEKI Brand Name for Netherton Syndrome Therapy
Quoin Pharmaceuticals has received conditional approval from the US Food and Drug Administration FDA for QYLEKI as the proposed brand name of QRX its investigational treatment for Netherton Syndrome



